Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Natriumoxybat, ATC N07XX04

Conclusion of non-exclusive rebate agreements in accordance with §§ 130a (8)/130c (1) SGB V for medicinal products with the above-mentioned active ingredient within the period from 01.09.2026 to 31.08.2028 with the possibility of concluding the contract at any time (open-house model). In the open-house procedure, medicinal products according to the BfArM list pursuant to § 35 (5a) SGB V (paediatric medicinal products) are excluded.